Novo Nordisk (NYSE: NVO) is the company behind diabetes and weight-loss treatments Ozempic and Wegovy. Business has been booming as demand for those drugs has left the company in a rush to add capacity so that it can fill orders. The stock has made for a hot buy this year, already rising 23% since the start of January.

But just how much would you have made if you had invested in the stock at the start of 2020? Let's have a look.

On Jan. 2, 2020, shares of Novo Nordisk opened at a price of $58.31. The healthcare stock was coming off an already strong year in 2019 during which its share price rose by 26%. But even if you had bought shares of the stock back then, you would still be sitting on some massive gains right now.

Continue reading

Source Fool.com